EMEA (Europe, Middle East and Africa) Acne Vulgaris Treatment Market Report 2018

payment-methods
Secure Payment Methods

The Acne Vulgaris Treatment market research report from Marketresearchpro consolidates the most important industry information while highlighting essential and valuable data regarding the status quo and trajectory of the Acne Vulgaris Treatment industry with forecasts through next 5 years.

A management summary, key facts & figures, SWOT analysis and chief executive quotes on the latest developments in Acne Vulgaris Treatment industry provide a substantial introduction. The report additionally provides quantitative information regarding Acne Vulgaris Treatment industry financial numbers, selected key players and company details, as well as employee and salary data.

In the coming years, Acne Vulgaris Treatment market will continue to focus their efforts on product innovation in order to attract new consumers and keep existing consumers loyal to specific brands.

Below is the majority of the content covered in this report

  • Acne Vulgaris Treatment Product details, including pictures and technical specifications
  • Acne Vulgaris Treatment manufacturers, distributors and channels
  • Major players present in the Acne Vulgaris Treatment
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

This report covers a strategic profiling of the following key players in the Acne Vulgaris Treatment market

  • Common Pharma Inc
  • Cutanea Life Sciences Inc
  • Dermira Inc
  • ELORAC Inc
  • Ensol Biosciences Inc
  • Foamix Pharmaceuticals Ltd
  • Galderma SA
  • GlaxoSmithKline Plc
  • Helix BioMedix Inc
  • Hovione FarmaCiencia SA
  • Lee’s Pharmaceutical Holdings Ltd
  • LEO Pharma A/S
  • Novabiotics Ltd
  • Novan Inc
  • Novartis AG
  • Paratek Pharmaceuticals Inc
  • Pfizer Inc
  • Phosphagenics Ltd

The report covers the information pertaining to following geographies

  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Benelux;
  • Saudi Arabia
  • Israel
  • UAE
  • Iran;
  • South Africa
  • Nigeria
  • Egypt
  • Algeria.

Additionally, the market is segmented by the following sectors

  • CB-0601
  • CJM-112
  • CLS-007
  • Dapsone
  • DFD-10
  • DLX-2323
  • Others

Please contact us if you are looking for any other possible breakdown across the products.

Not only this, figures covering the end user applications are also provided according to the following classification

  • Clinic
  • Hospital
  • Others

In summary, the report serves to study and analyse the Acne Vulgaris Treatment size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acne Vulgaris Treatment, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • EMEA (Europe, Middle East and Africa) Acne Vulgaris Treatment Market Report 2018
  • 1 Acne Vulgaris Treatment Overview
    • 1.1 Product Overview and Scope of Acne Vulgaris Treatment
    • 1.2 Classification of Acne Vulgaris Treatment
      • 1.2.1 EMEA Acne Vulgaris Treatment Market Size (Sales) Comparison by Type (2013-2025)
      • 1.2.2 EMEA Acne Vulgaris Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
      • 1.2.3 CB-0601
      • 1.2.4 CJM-112
      • 1.2.5 CLS-007
      • 1.2.6 Dapsone
      • 1.2.7 DFD-10
      • 1.2.8 DLX-2323
      • 1.2.9 Others
    • 1.3 EMEA Acne Vulgaris Treatment Market by Application/End Users
      • 1.3.1 EMEA Acne Vulgaris Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
      • 1.3.2 Clinic
      • 1.3.3 Hospital
      • 1.3.4 Others
    • 1.4 EMEA Acne Vulgaris Treatment Market by Region
      • 1.4.1 EMEA Acne Vulgaris Treatment Market Size (Value) Comparison by Region (2013-2025)
      • 1.4.2 Europe Status and Prospect (2013-2025)
      • 1.4.3 Middle East Status and Prospect (2013-2025)
      • 1.4.4 Africa Status and Prospect (2013-2025)
    • 1.5 EMEA Market Size (Value and Volume) of Acne Vulgaris Treatment (2013-2025)
      • 1.5.1 EMEA Acne Vulgaris Treatment Sales and Growth Rate (2013-2025)
      • 1.5.2 EMEA Acne Vulgaris Treatment Revenue and Growth Rate (2013-2025)
  • 2 EMEA Acne Vulgaris Treatment Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    • 2.1 EMEA Acne Vulgaris Treatment Market Competition by Players/Manufacturers
      • 2.1.1 EMEA Acne Vulgaris Treatment Sales Volume and Market Share of Major Players (2013-2018)
      • 2.1.2 EMEA Acne Vulgaris Treatment Revenue and Share by Players (2013-2018)
      • 2.1.3 EMEA Acne Vulgaris Treatment Sale Price by Players (2013-2018)
    • 2.2 EMEA Acne Vulgaris Treatment (Volume and Value) by Type/Product Category
      • 2.2.1 EMEA Acne Vulgaris Treatment Sales and Market Share by Type (2013-2018)
      • 2.2.2 EMEA Acne Vulgaris Treatment Revenue and Market Share by Type (2013-2018)
      • 2.2.3 EMEA Acne Vulgaris Treatment Sale Price by Type (2013-2018)
    • 2.3 EMEA Acne Vulgaris Treatment (Volume) by Application
    • 2.4 EMEA Acne Vulgaris Treatment (Volume and Value) by Region
      • 2.4.1 EMEA Acne Vulgaris Treatment Sales and Market Share by Region (2013-2018)
      • 2.4.2 EMEA Acne Vulgaris Treatment Revenue and Market Share by Region (2013-2018)
      • 2.4.3 EMEA Acne Vulgaris Treatment Sales Price by Region (2013-2018)
  • 3 Europe Acne Vulgaris Treatment (Volume, Value and Sales Price), by Players, Countries, Type and Application
    • 3.1 Europe Acne Vulgaris Treatment Sales and Value (2013-2018)
      • 3.1.1 Europe Acne Vulgaris Treatment Sales Volume and Growth Rate (2013-2018)
      • 3.1.2 Europe Acne Vulgaris Treatment Revenue and Growth Rate (2013-2018)
    • 3.2 Europe Acne Vulgaris Treatment Sales and Market Share by Type
    • 3.3 Europe Acne Vulgaris Treatment Sales and Market Share by Application
    • 3.4 Europe Acne Vulgaris Treatment Sales Volume and Value (Revenue) by Countries
      • 3.4.1 Europe Acne Vulgaris Treatment Sales Volume by Countries (2013-2018)
      • 3.4.2 Europe Acne Vulgaris Treatment Revenue by Countries (2013-2018)
      • 3.4.3 Germany Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 3.4.4 France Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 3.4.5 UK Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 3.4.6 Russia Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 3.4.7 Italy Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 3.4.8 Benelux Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
  • 4 Middle East Acne Vulgaris Treatment (Volume, Value and Sales Price), by Region, Type and Application
    • 4.1 Middle East Acne Vulgaris Treatment Sales and Value (2013-2018)
      • 4.1.1 Middle East Acne Vulgaris Treatment Sales Volume and Growth Rate (2013-2018)
      • 4.1.2 Middle East Acne Vulgaris Treatment Revenue and Growth Rate (2013-2018)
    • 4.2 Middle East Acne Vulgaris Treatment Sales and Market Share by Type
    • 4.3 Middle East Acne Vulgaris Treatment Sales and Market Share by Application
    • 4.4 Middle East Acne Vulgaris Treatment Sales Volume and Value (Revenue) by Countries
      • 4.4.1 Middle East Acne Vulgaris Treatment Sales Volume by Countries (2013-2018)
      • 4.4.2 Middle East Acne Vulgaris Treatment Revenue by Countries (2013-2018)
      • 4.4.3 Saudi Arabia Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 4.4.4 Israel Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 4.4.5 UAE Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 4.4.6 Iran Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
  • 5 Africa Acne Vulgaris Treatment (Volume, Value and Sales Price) by Players, Countries, Type and Application
    • 5.1 Africa Acne Vulgaris Treatment Sales and Value (2013-2018)
      • 5.1.1 Africa Acne Vulgaris Treatment Sales Volume and Growth Rate (2013-2018)
      • 5.1.2 Africa Acne Vulgaris Treatment Revenue and Growth Rate (2013-2018)
    • 5.2 Africa Acne Vulgaris Treatment Sales and Market Share by Type
    • 5.3 Africa Acne Vulgaris Treatment Sales and Market Share by Application
    • 5.4 Africa Acne Vulgaris Treatment Sales Volume and Value (Revenue) by Countries
      • 5.4.1 Africa Acne Vulgaris Treatment Sales Volume by Countries (2013-2018)
      • 5.4.2 Africa Acne Vulgaris Treatment Revenue by Countries (2013-2018)
      • 5.4.3 South Africa Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 5.4.4 Nigeria Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 5.4.5 Egypt Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
      • 5.4.6 Algeria Acne Vulgaris Treatment Sales and Growth Rate (2013-2018)
  • 6 EMEA Acne Vulgaris Treatment Manufacturers/Players Profiles and Sales Data
    • 6.1 Common Pharma Inc
      • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.1.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.1.2.1 Product A
        • 6.1.2.2 Product B
      • 6.1.3 Common Pharma Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.1.4 Main Business/Business Overview
    • 6.2 Cutanea Life Sciences Inc
      • 6.2.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.2.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.2.2.1 Product A
        • 6.2.2.2 Product B
      • 6.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.2.4 Main Business/Business Overview
    • 6.3 Dermira Inc
      • 6.3.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.3.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.3.2.1 Product A
        • 6.3.2.2 Product B
      • 6.3.3 Dermira Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.3.4 Main Business/Business Overview
    • 6.4 ELORAC Inc
      • 6.4.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.4.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.4.2.1 Product A
        • 6.4.2.2 Product B
      • 6.4.3 ELORAC Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.4.4 Main Business/Business Overview
    • 6.5 Ensol Biosciences Inc
      • 6.5.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.5.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.5.2.1 Product A
        • 6.5.2.2 Product B
      • 6.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.5.4 Main Business/Business Overview
    • 6.6 Foamix Pharmaceuticals Ltd
      • 6.6.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.6.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.6.2.1 Product A
        • 6.6.2.2 Product B
      • 6.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.6.4 Main Business/Business Overview
    • 6.7 Galderma SA
      • 6.7.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.7.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.7.2.1 Product A
        • 6.7.2.2 Product B
      • 6.7.3 Galderma SA Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.7.4 Main Business/Business Overview
    • 6.8 GlaxoSmithKline Plc
      • 6.8.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.8.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.8.2.1 Product A
        • 6.8.2.2 Product B
      • 6.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.8.4 Main Business/Business Overview
    • 6.9 Helix BioMedix Inc
      • 6.9.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.9.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.9.2.1 Product A
        • 6.9.2.2 Product B
      • 6.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.9.4 Main Business/Business Overview
    • 6.10 Hovione FarmaCiencia SA
      • 6.10.1 Company Basic Information, Manufacturing Base and Competitors
      • 6.10.2 Acne Vulgaris Treatment Product Type, Application and Specification
        • 6.10.2.1 Product A
        • 6.10.2.2 Product B
      • 6.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
      • 6.10.4 Main Business/Business Overview
    • 6.11 Lee’s Pharmaceutical Holdings Ltd
    • 6.12 LEO Pharma A/S
    • 6.13 Novabiotics Ltd
    • 6.14 Novan Inc
    • 6.15 Novartis AG
    • 6.16 Paratek Pharmaceuticals Inc
    • 6.17 Pfizer Inc
    • 6.18 Phosphagenics Ltd
  • 7 Acne Vulgaris Treatment Manufacturing Cost Analysis
    • 7.1 Acne Vulgaris Treatment Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Price Trend of Key Raw Materials
      • 7.1.3 Key Suppliers of Raw Materials
      • 7.1.4 Market Concentration Rate of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
      • 7.2.1 Raw Materials
      • 7.2.2 Labor Cost
      • 7.2.3 Manufacturing Expenses
    • 7.3 Manufacturing Process Analysis of Acne Vulgaris Treatment
  • 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    • 8.1 Acne Vulgaris Treatment Industrial Chain Analysis
    • 8.2 Upstream Raw Materials Sourcing
    • 8.3 Raw Materials Sources of Acne Vulgaris Treatment Major Manufacturers in 2017
    • 8.4 Downstream Buyers
  • 9 Marketing Strategy Analysis, Distributors/Traders
    • 9.1 Marketing Channel
      • 9.1.1 Direct Marketing
      • 9.1.2 Indirect Marketing
      • 9.1.3 Marketing Channel Development Trend
    • 9.2 Market Positioning
      • 9.2.1 Pricing Strategy
      • 9.2.2 Brand Strategy
      • 9.2.3 Target Client
    • 9.3 Distributors/Traders List
  • 10 Market Effect Factors Analysis
    • 10.1 Technology Progress/Risk
      • 10.1.1 Substitutes Threat
      • 10.1.2 Technology Progress in Related Industry
    • 10.2 Consumer Needs/Customer Preference Change
    • 10.3 Economic/Political Environmental Change
  • 11 EMEA Acne Vulgaris Treatment Market Forecast (2018-2025)
    • 11.1 EMEA Acne Vulgaris Treatment Sales, Revenue and Price Forecast (2018-2025)
      • 11.1.1 EMEA Acne Vulgaris Treatment Sales and Growth Rate Forecast (2018-2025)
      • 11.1.2 EMEA Acne Vulgaris Treatment Revenue and Growth Rate Forecast (2018-2025)
      • 11.1.3 EMEA Acne Vulgaris Treatment Price and Trend Forecast (2018-2025)
    • 11.2 EMEA Acne Vulgaris Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    • 11.3 Europe Acne Vulgaris Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    • 11.4 Middle Eastt Acne Vulgaris Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    • 11.5 Africa Acne Vulgaris Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    • 11.6 EMEA Acne Vulgaris Treatment Sales Forecast by Type (2018-2025)
    • 11.7 EMEA Acne Vulgaris Treatment Sales Forecast by Application (2018-2025)
  • 12 Research Findings and Conclusion
  • 13 Appendix
    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

Request a FREE Sample


PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers

Request a FREE Sample